Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia

AIDS

Volumn 24, Issue 11, 2010, Pages 1641-1649

  Pasternak, Alexander O ^a   Jurriaans, Suzanne ^b   Bakker, Margreet ^a   Berkhout, Ben ^a   Lukashov, Vladimir V ^a  

^a Center for Infection and Immunity Amsterdam   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

DNA viral; HIV infections; HIV 1; longitudinal studies; RNA viral; viral load

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIREMIA; VIRION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; DNA, VIRAL; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL LOAD; VIREMIA;

EID: 77954348714     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833b3171     Document Type: Article

References (28)

1. Jurriaans S, Van Gemen B, Weverling GJ, Van Strijp D, Nara P, Coutinho R, et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994; 204:223-233.
2. Henrard DR, Phillips JF, Muenz LR, Blattner WA, Wiesner D, Eyster ME, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995; 274:554-558.
3. Spijkerman IJ, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, Miedema F, et al. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men. AIDS 1997; 11:1383-1388.
4. Geskus RB, Prins M, Hubert JB, Miedema F, Berkhout B, Rouzioux C, et al. The HIV RNA setpoint theory revisited. Retrovirology 2007; 4:65.
5. Korenromp EL, Williams BG, Schmid GP, Dye C. Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection: a quantitative review. PLoS One 2009; 4:e5950.
6. Sabin CA, Devereux H, Phillips AN, Hill A, Janossy G, Lee CA, et al. Course of viral load throughout HIV-1 infection. J Acquir Immune Defic Syndr 2000; 23:172-177.
7. O?Brien TR, Rosenberg PS, Yellin F, Goedert JJ. Longitudinal HIV-1 RNA levels in a cohort of homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:155-161.
8. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4R lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954.
9. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, Kitahata M, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006; 296:1498-1506.
10. Fischer M, Joos B, Niederost B, Kaiser P, Hafner R, von Wyl V, et al. Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy. Retrovirology 2008; 5:107.
11. Zanchetta M, Walker S, Burighel N, Bellanova D, Rampon O, Giaquinto C, et al. Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretro-viral therapy. J Infect Dis 2006; 193:1718-1727.
12. Pasternak AO, Jurriaans S, Bakker M, Prins JM, Berkhout B, Lukashov VV. Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetect-able plasma viremia predict the therapy outcome. PLoS One 2009; 4:e8490.
13. Minga AK, Anglaret X, d? Aquin TT, Chaix ML, Dohoun L, Abo Y, et al. HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected west African adults. J Acquir Immune Defic Syndr 2008; 48:350-354.
14. Rouzioux C, Hubert JB, Burgard M, Deveau C, Goujard C, Bary M, et al. Early levels of HIV-1 DNA in peripheral blood mono-nuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4R T cell counts. J Infect Dis 2005; 192:46-55.
15. Kostrikis LG, Touloumi G, Karanicolas R, Pantazis N, Anastas-sopoulou C, Karafoulidou A, et al. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J Virol 2002; 76:10099-10108.
16. Saksela K, Stevens C, Rubinstein P, Baltimore D. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbersofCD4R lymphocytes. Proc Natl Acad SciUSA1994; 91:1104-1108.
17. Michael NL, Mo T, Merzouki A, O?Shaughnessy M, Oster C, Burke DS, et al. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J Virol 1995; 69:1868-1877.
18. Gupta P, Kingsley L, Armstrong J, Ding M, Cottrill M, Rinaldo C. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 1993; 196:586-595.
19. Furtado MR, Kingsley LA, Wolinsky SM. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4R T-cell number decline in human immunodeficiency virus type 1-infected individuals. J Virol 1995; 69:2092-2100.
20. Bagnarelli P, Valenza A, Menzo S, Manzin A, Scalise G, Varaldo PE, et al. Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol 1994; 68:2495-2502.
21. Pasternak AO, Adema KW, Bakker M, Jurriaans S, Berkhout B, Cornelissen M, et al. Highly sensitive methods based on semi-nested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA. J Clin Microbiol 2008; 46:2206-2211.
22. BoomR, Sol CJ, Salimans MM, Jansen CL, Wertheim-Van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495-503.
23. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947.
24. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009; 5:e1000791.
25. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, et al. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 2010; 201:618-626.
26. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, et al. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS One 2008; 3:e3907.
27. Rotger M, Dang KK, Fellay J, Heinzen EL, Feng S, Descombes P, et al. Genome-wide mRNA expression correlates of viral control in CD4R T-cells from HIV-1-infected individuals. PLoS Pathog 2010; 6:e1000781.
28. deWolfF, SpijkermanI, SchellekensPT, LangendamM, Kuiken C, Bakker M, et al. AIDS prognosis based on HIV-1 RNA, CD4R T-cellcount andfunction: markers withreciprocal predictivevalue over time after seroconversion. AIDS 1997; 11:1799-1806.